UK-funded study to investigate patients’ experience of cell and gene therapies
Innovate UK is helping to fund the PROmics study, a programme designed to assess the effect of cell therapies on patient symptoms and quality of life.
Archives for December 5, 2018
Leukemia licensing deal could potentially cost Janssen more than $1.8bn
Janssen has entered a global licensing agreement with argenx to develop and commercialize a treatment for acute myeloid leukemia.
Start-up develops cell replacement therapy to ‘make hair loss history’
Scientists, hair transplant surgeons and patients have collaborated to develop personalised cell replacement therapies for baldness.